Toshihiko Inoue

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis.

Kenji Sugio, Tatsuhiro Ishida, Hideki Yokoyama et al. · PubMed · 1992 · 167 citations

Medicine, Genetics, Oncology +17

Treatment of carcinoma of the uterine cervix by remotely controlled afterloading intracavitary radiotherapy with high-dose rate: A comparative study with a low-dose rate system

Yasushi Shigematsu, Kinji Nishiyama, Norie Masaki et al. · International Journal of Radiation Oncology*Biology*Physics · 1983 · 167 citations

Medicine, Oncology, Radiation Oncology +11

High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: Treatment description and preliminary results of a phase I/II clinical trial

Yasuo Yoshioka, Takayuki Nose, Ken Yoshida et al. · International Journal of Radiation Oncology*Biology*Physics · 2000 · 146 citations

Medicine, Radiation Oncology, Urology +11